Axel Stenmark Tullberg

Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial

Anikó Kovács, Axel Stenmark Tullberg, Elisabeth Werner Rönnerman et al. · Journal of Clinical Oncology · 2019 · 67 citations

Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial

Axel Stenmark Tullberg, Henri Puttonen, Martin Sjöström et al. · Clinical Cancer Research · 2020 · 29 citations · Full text

Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial

Aglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg et al. · European Journal of Cancer · 2022 · 21 citations · Full text

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial

Carina Strell, Axel Stenmark Tullberg, Reidunn J. Edelmann et al. · Breast Cancer Research and Treatment · 2021 · 18 citations · Full text

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

Axel Stenmark Tullberg, Martin Sjöström, Lena Tran et al. · Journal for ImmunoTherapy of Cancer · 2023 · 14 citations · Full text